Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trialsDavide Mauri, Antonis Valachis, Nikolaos P Polyzos, et al.
Cancer Letters|July 22, 2009
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancerPanayiotis A Theodoropoulos, Hara Polioudaki, Sofia Agelaki, et al.
Clinical Breast Cancer|June 25, 2014
Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancerKonstantinos Tryfonidis, Maria Kafousi, Maria Perraki, et al.
Reviews on Recent Clinical Trials|May 12, 2025
A Prospective Study on the Role of Strain Echocardiography in Detecting Early Radiation-induced Cardiotoxicity in Left-sided Breast Cancer PatientsAreti Gkantaifi, Christodoulos Papadopoulos, Maria Toumpourleka, et al.
Anticancer Research|August 10, 2002
A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapyStylianos Souglakos John Kakolyris, Charalambos Kouroussis, Michael Koukourakis, et al.
Molecular Oncology|June 30, 2019
PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison studyEleni Tzanikou, Athina Markou, Eleni Politaki, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2009
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancerVasiliki Bozionelou, Kostas Kalbakis, Lambros Vamvakas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2012
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancerAlexandra Voutsina, Maria Tzardi, Aristea Kalikaki, et al.
Molecular Cancer Therapeutics|June 20, 2013
Apoptotic circulating tumor cells in early and metastatic breast cancer patientsGalatea Kallergi, Georgios Konstantinidis, Harris Markomanolaki, et al.
Cancers|December 16, 2020
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' SettingMarcus Skribek, Konstantinos Rounis, Dimitrios Makrakis, et al.
Pageof 12